mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |